A randomized, double-blinded, placebo-controlled, single-center, comparative study evaluating Phaseolean® safety and efficacy in overweight/obese participants

被引:0
作者
Singh, Shashi Chandrama [1 ]
Singh, Harshpal [1 ]
Choudhary, Muskan [1 ]
机构
[1] Ambe Phytoextracts Pvt Ltd, Res & Dev Ctr, Bironkhal 246276, Uttarakhand, India
关键词
White kidney bean extract; Obesity; Weight management; alpha-amylase inhibitory activity; Nutraceutical; PHASEOLUS-VULGARIS EXTRACT; CARBOHYDRATE-ABSORPTION; OBESITY; TOXICITY;
D O I
10.1016/j.heliyon.2024.e35144
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Scope: Phaseolean (R), a standardized water extract of Phaseolus vulgaris or white kidney bean, exhibits alpha-amylase inhibitory property, which decreases calorie absorption by preventing or delaying carbohydrate digestion, thus supporting weight management. This randomized, doubleblind, placebo-controlled, single-center comparative study (Clinical trial registration number: CTRI/2023/02/049440, Registered on: February 03, 2023) evaluated the safety and efficacy of Phaseolean (R) in weight management in overweight or obese participants upon regular intake at two different doses compared with placebo. Method: Sixty-six participants were enrolled and randomly divided into three groups, considering the inclusion & exclusion criteria. Each group was assigned a specific daily dosage for three meals: Phaseolean (R) 1500 mg/day (500 mg per meal), Phaseolean (R) 3000 mg/day (1000 mg per meal), or placebo 1500 mg/day (500 mg per meal), administered thrice a day before meals for 45 consecutive days. Body weight; body mass index (BMI); skinfold fat thickness; waist, hip, and thigh circumferences; and blood biochemical parameters were monitored and analyzed to evaluate the effects of these interventions. Results and conclusions: Of the 66 enrolled participants, 62 completed the study. Treatment with Phaseolean (R) 1500 mg/day reduced the weight by an average of 2.10 kg (0.33 kg/week), while that with 3000 mg/day was 1.94 kg (0.30 kg/week); 0.13 kg weight loss (0.02 kg/week) was observed in the placebo group after 45 days, showing significant differences between the Phaseolean (R) and placebo groups (p < 0.01). BMI, body fat, skinfold fat thickness, and the waist, hip, and thigh circumference were significantly reduced (p < 0.01) in both Phaseolean (R) groups compared with those in the placebo group, which showed no significant changes. No adverse effects were observed during the clinical trial period. Phaseolean (R) 1500 mg/day dose was more effective in weight reduction than the 3000 mg/day higher dose. Therefore, Phaseolean (R) can be used to support healthy weight management.
引用
收藏
页数:14
相关论文
共 17 条
  • [11] Udani J, 2007, ALTERN THER HEALTH M, V13, P32
  • [12] Udani Jay, 2004, Altern Med Rev, V9, P63
  • [13] Prevalence of Obesity in India and Its Neurological Implications: A Multifactor Analysis of a Nationwide Cross-Sectional Study
    Venkatrao, Murali
    Nagarathna, Raghuram
    Majumdar, Vijaya
    Patil, Suchitra S.
    Rathi, Sunanda
    Nagendra, Hongasandra
    [J]. ANNALS OF NEUROSCIENCES, 2020, 27 (3-4) : 153 - 161
  • [14] Vinson J.A., 2009, The Open Nutraceuticals Journal, V2, P88, DOI [10.2174/1876396000902010088, DOI 10.2174/1876396000902010088]
  • [15] Regular intake of white kidney beans extract (Phaseolus vulgaris L.) induces weight loss compared to placebo in obese human subjects
    Wang, Shenli
    Chen, Lishui
    Yang, Haiying
    Gu, Jinghan
    Wang, Jing
    Ren, Fazheng
    [J]. FOOD SCIENCE & NUTRITION, 2020, 8 (03): : 1315 - 1324
  • [16] WHO, Obesity
  • [17] worldobesity, 2022, World Obesity Atlas